UTAH MEDICAL PRODUCTS INC 8-K

What Happened

• Utah Medical Products Inc. (UTMD) filed an 8-K on May 4, 2026 reporting the results of its annual meeting held May 1, 2026. Stockholders voted on director elections, ratification of the independent auditor, and an advisory vote on executive compensation.
• Director election results: Ernst G. Hoyer received 1,330,333 votes for and 1,070,640 withheld (372,329 broker non‑votes); James H. Beeson received 1,708,941 votes for and 692,032 withheld (372,329 broker non‑votes).
• Auditor ratified: Haynie & Co. was ratified as the company’s independent public accounting firm for the year ending December 31, 2026 (For 2,753,278; Against 16,273; Abstentions 3,751).
• Advisory vote on executive compensation (say-on-pay): Approved on an advisory basis (For 2,354,919; Against 38,451; Abstentions 7,603; 372,329 broker non‑votes). The company will continue to include annual advisory votes on executive compensation.

Key Details

• Annual meeting date: May 1, 2026; 8-K filed May 4, 2026.
• Director tallies: Hoyer — For 1,330,333 / Withheld 1,070,640; Beeson — For 1,708,941 / Withheld 692,032.
• Auditor ratification: Haynie & Co. — For 2,753,278; Against 16,273; Abstentions 3,751.
• Say-on-pay: For 2,354,919; Against 38,451; Abstentions 7,603; broker non‑votes 372,329.

Why It Matters

• These voting outcomes confirm the board composition (Hoyer and Beeson) and continuity of the company’s auditor for 2026, which affect governance and financial oversight.
• The strong advisory approval for executive compensation means investors gave non‑binding support to the company’s pay practices; the company will continue to hold annual advisory votes on executive pay, providing recurring shareholder input.
• Broker non‑votes indicate a portion of shares held by brokers without voting instructions, which can affect reported totals; investors should consider vote participation when assessing shareholder support.